Upside – $AEMD +403% (merger agreement with North Immunology adds an IL-13 x IL-18 bispecific-antibody program for atopic dermatitis) – $GNRC +30% (Amazon supply agreement includes $2.4B of backup-generator deliveries expected during 2027-2028) – $VEEA +30% (non-binding combination term sheet with NovaGen targets a $750M AI-health platform) – $DTSS +12% (strategic cooperation expands into AI-powered …
Read in context ›DataMeds AI Stock (MEDS)
Track DataMeds AI stock through TheStreet Pro's latest coverage, including articles, Daily Diary mentions, TheStreet Pro portfolio activity, contributor watchlist signals, and Pro price levels.
MEDS
DataMeds AI
general
$4.56
▼ -62.43 (-91.14%) past year
Market Cap
$5.14M
P/E Ratio
—
1Y Return
-91.14%
EPS (TTM)
-$43.30
Read the latest TheStreet Pro articles mentioning DataMeds AI, including market roundups, portfolio updates, trade ideas, and investing analysis.
Articles
0 articlesNo articles mentioning MEDS yet.
Daily Diary Mentions
1 mentionUpside, Downside Movers in the Morning